The customer is a popular mid-size pharma company in the process of collaborating with an industry counterpart to add a therapeutic Fc-modified antibody to their oncology portfolio in order to provide advanced treatment options for their patients in the United States (US) and the European Union (EU).
To promote the new product, the customer was looking to create a new collaborative marketing technology (MarTech) framework that would help deliver effective and engaging communication and user experiences to healthcare professionals (HCPs). Additionally, strict compliance with General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act (HIPAA) regulations for consent management was of utmost importance in the EU.
A high rate of unsubscribes due to uncoordinated, excessive, and nonpersonalized content stemming from the use of multiple siloed MarTech tools, including customer relationship management (CRM) and email marketing platforms managed by different teams
Managing and updating unsubscribes across each individual siloed tool was a completely manual process. This manual approach increased the risk of unforeseen errors, potentially subjecting the client to significant financial penalties
The existing consent management process relied heavily on a thirdparty vendor, which was occasionally inaccurate and difficult to maintain